ARI a Key Presence at Recent BIO International Convention
Atlanta, GA (PRWEB) May 31, 2009 -- Aderans Research Institute Inc. (ARI) was a notable presence at the recent BIO International Convention. The leading hair regeneration company joined more than 1,800 companies from 58 countries around the globe at the world's largest annual event for the biotechnology industry, held May 18-21 at the Georgia World Congress Center.
Co-located in Atlanta and Philadelphia, ARI is actively engaged in the study of state-of-the-art cell-based hair regeneration for men and women. The company recently launched Phase 2 of its clinical study to assess the impact of its regenerative cell treatment on pattern hair loss, also known as androgenetic alopecia. Phase 2 of the study is being conducted in six U.S. cities: Atlanta, Boston, New York, Raleigh, Houston, and Washington DC. Phase 1 was conducted exclusively in the United Kingdom.
"Our research is focused on generating a tissue engineering solution to the regeneration of hair," said Kurt Stenn, MD, Vice President and Chief Scientific Officer at ARI. "We're using the hair cells from hair follicles and researching methods to promote their growth in controlled laboratory environments. If successful, we'll then be able to recombine the cells and restore them to the scalp, where they would ultimately elicit hair growth."
A dynamic field on the cutting-edge of the hair restoration industry, cell treatment represents a major advance on traditional hair transplant procedures, promising to overcome a key limitation of conventional transplantation: a finite hair supply for any one person. Through leading edge cell engineering, Aderans Research is pioneering efforts to multiply existing hair cells capable of eliciting hair growth, providing patients with a comprehensive solution to hair loss regardless of the quantity of their existing hair.
About the BIO International Convention:
The BIO International Convention is the largest global event for the biotechnology industry, offering key networking and partnering opportunities, and providing insight on major trends affecting the industry. The convention is produced by BIO, the world's largest biotechnology organization, representing more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and abroad. BIO works to create a favorable policy environment for biotechnological innovation. Its members are involved in marketing, research and development across the healthcare, agriculture, industrial and environmental biotechnology fields.
Learn more at: http://convention.bio.org/
About Aderans Research:
Aderans Research is dedicated to solving the pervasive problem of hair loss and becoming the world leader in the research and development of safe, effective cell engineered products for hair regeneration.
With offices in Atlanta and Philadelphia, Aderans Research Institute is a subsidiary of Aderans Company, Ltd, the world's largest wig manufacturer, and an affiliate of Bosley, a global leader in medical hair restoration.
More information on ARI's study outcomes will be released as studies conclude. To see ARI's latest clinical updates, please visit http://aderansresearch.com/ari_clinicalupdates.html
Additional information on ARI can be found at www.aderansresearch.com.
Read the full story at http://www.prweb.com/releases/hair/regeneration/prweb2478234.htm.
Copyright©2009 Vocus, Inc.
All rights reserved